These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16734138)

  • 1. Proinflammatory cytokines, soluble Fas receptor, nitric oxide and angiotensin converting enzyme in congestive heart failure.
    El Sherif WT; El Tooney LF; Meki AR; Abdel Moneim A
    Egypt J Immunol; 2005; 12(1):39-48. PubMed ID: 16734138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
    Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
    Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
    Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
    J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation and role of the tumor necrosis factor-alpha in congestive heart failure].
    Bachetti T; Comini L; Agnoletti L; Gaia G; Milanesi B; Curello S; Corti A; Ferrari R; Visioli O
    Cardiologia; 1996 Apr; 41(4):343-7. PubMed ID: 8674103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
    Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
    J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood Content of Markers of Inflammation and Cytokines in Patients With Alcoholic Cardiomyopathy and Ischemic Heart Disease at Various Stages of Heart Failure].
    Panchenko LF; Moiseev VS; Pirozhkov SV; Terebilina NN; Naumova TA; Baronets VIu; Goncharov AS
    Kardiologiia; 2015; 55(3):41-8. PubMed ID: 26320289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
    Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
    Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
    Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
    Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
    Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
    Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure.
    Samsonov M; Lopatin J; Tilz GP; Artner-Dworzak E; Nassonov E; Mareev V; Belenkov J; Wachter H; Fuchs D
    J Intern Med; 1998 Feb; 243(2):93-8. PubMed ID: 9566636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of plasma levels of tumor necrosis factor-alpha and interleukin-6 in predicting the severity and prognosis in patients with congestive heart failure.
    Pan JP; Liu TY; Chiang SC; Lin YK; Chou CY; Chan WL; Lai ST
    J Chin Med Assoc; 2004 May; 67(5):222-8. PubMed ID: 15357108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of astraglus injection on serum apoptosis relevant factors in patients with chronic heart failure].
    Zhang JG; Yang N; He H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 May; 25(5):400-3. PubMed ID: 15957829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
    Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
    Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of amlodipine on serum level of some cytokines in patients with congestive heart failure].
    Salomon P; Halawa B; Karolko B
    Pol Arch Med Wewn; 2003 Feb; 109(2):149-55. PubMed ID: 12879778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
    Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure.
    Hamdy NM
    Med Sci Monit; 2011 Feb; 17(3):CR174-9. PubMed ID: 21358606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.